PENG vs FICB Anesthesia for Hip Fracture
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two types of anesthesia to manage pain in people with hip fractures. It compares the Pericapsular Nerve Group (PENG) block and the Fascia Iliaca Compartment Block (FICB) to determine which provides better pain control in the emergency department. Individuals with a fracture in the upper part of the thigh bone may qualify for this trial. As an unphased trial, it offers participants the chance to contribute to important research that could enhance pain management options for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these anesthesia techniques are safe for hip fracture patients?
Research shows that both the PENG block and FICB are safe for managing pain in people with hip fractures.
Studies have found the PENG block effective and safe, with no major safety issues for patients undergoing hip fracture surgery. This method helps manage hip pain and can be used in emergency rooms.
Similarly, the FICB has been well-researched and proven safe for pain relief in hip fracture patients. Reports consistently show no complications from its use, and many reviews highlight its effectiveness in reducing pain before surgery.
Both treatments have strong safety records based on existing studies, making them well-tolerated options for those considering joining clinical trials for hip fracture pain management.12345Why are researchers excited about this trial?
Researchers are excited about these anesthesia techniques because they promise more targeted pain relief for hip fracture patients. The PENG block focuses on numbing specific nerves linked directly to hip pain, potentially offering better pain control with fewer side effects compared to traditional methods like general anesthesia or systemic pain medication. The FICB also provides localized pain relief, but through a different nerve block technique, which might be easier to administer and just as effective. These techniques could improve patient comfort and recovery, making them an appealing option for both patients and healthcare providers.
What evidence suggests that this trial's treatments could be effective for hip fracture pain control?
This trial will compare the effectiveness of the Pericapsular Nerve Group (PENG) block and the Fascia Iliaca Compartment Block (FICB) for patients with hip fractures. Studies have shown that the PENG block effectively reduces pain after hip surgery, aids in positioning during anesthesia, and lowers the need for opioids, which are strong painkillers with many side effects. Research indicates that the FICB also provides significant pain relief within a few hours and reduces opioid use for up to two days. Both treatments have successfully eased hip fracture pain and minimized opioid use, making them promising options for managing pain in these situations.36789
Are You a Good Fit for This Trial?
This trial is for emergency department patients with hip fractures, specifically femoral neck or intertrochanteric fractures. Participants must consent to the procedure and not have allergies to local anesthetics. Those with severe injuries causing instability, serious unstable medical conditions, or hemodynamic instability cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the PENG block or FICB for pain control in the emergency department
Follow-up
Participants are monitored for pain control and opioid use until surgery or up to 24 hours
What Are the Treatments Tested in This Trial?
Interventions
- FICB
- PENG
FICB is already approved in European Union, United States, Canada for the following indications:
- Pain management for hip fractures and hip surgery
- Pain management for hip fractures and hip surgery
- Pain management for hip fractures and hip surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Virginia
Lead Sponsor